Finance

Lists
DRMA:NASDAQ
Dermata Therapeutics Inc
$1.46
-7.01%
(-0.11) 1D
$1.42
-2.74% (-0.040)
After hours
Closed: Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRMA...
Open
$1.47
High
$1.55
Low
$1.40
Mkt. cap
5.87M
Avg. vol.
1.43M
Volume
421.58K
52-wk high
$6.22
52-wk low
$0.95
EPS
-$5.43
Beta
0.66
Shares outstanding
4.02M
No. of employees
9
Open
$1.47
High
$1.55
Low
$1.40
Mkt. cap
5.87M
Avg. vol.
1.43M
Volume
421.58K
52-wk high
$6.22
52-wk low
$0.95
EPS
-$5.43
Beta
0.66
Shares outstanding
4.02M
No. of employees
9
About Dermata Therapeutics Inc
CEO-
Employees9
Founded2014
Headquarters-
SectorBiotechnology
Websitedermatarx.com
Analyst ratings
Based on 1 analyst giving stock ratings to DRMA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for DRMA in the last 3 months
Highest
Current $1.46
$4.00 (+173.97%)
Average
$4.00 (+173.97%)
Lowest
$4.00 (+173.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Vendetti
Maxim Group
Buy
Maintained
$4.00
+174%
08/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
504.39K
526.62K
383.72K
212.56K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.26M
1.37M
1.54M
2.80M
Operating expense
1.76M
1.90M
1.93M
3.01M
Total operating expenses
1.76M
1.90M
1.93M
3.01M
Operating income
-1.76M
-1.90M
-1.93M
-3.01M
Other non operating income
-
-
-
-
EBT including unusual items
-1.69M
-1.86M
-1.85M
-2.97M
EBT excluding unusual items
-1.69M
-1.86M
-1.85M
-2.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.69M
-1.86M
-1.85M
-2.97M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
68.68K
38.50K
78.68K
46.50K
Interest expense
-
-
-
-
Net interest expenses
68.68K
38.50K
78.68K
46.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps